METTL16 and hepatocellular carcinoma: In the present study, to explore the potential biological role of METTL16 in HCC, we performed GSEA analysis in the TCGA cohort and found that low METTL16 level was associated with the activation of multiple metabolic pathways, implying a potential role of METTL16 in metabolic reprogramming.